Trial Profile
A phase 2 study to determine the safety and efficacy of inhaled dry powder mannitol in cystic fibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Feb 2024
Price :
$35
*
At a glance
- Drugs Mannitol (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Syntara Limited
- 04 Dec 2023 According to a Syntara Limited media release, Pharmaxis has changed its name to Syntara Limited